Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prophylactic Cranial Irradiation for Limited-Stage Small-Cell Lung Cancer Patients: Secondary Findings From the Prospective Randomized Phase 3 CONVERT Trial.
Levy A, Le Péchoux C, Mistry H, Martel-Lafay I, Bezjak A, Lerouge D, Padovani L, Taylor P, Faivre-Finn C. Levy A, et al. Among authors: taylor p. J Thorac Oncol. 2019 Feb;14(2):294-297. doi: 10.1016/j.jtho.2018.09.019. Epub 2018 Oct 4. J Thorac Oncol. 2019. PMID: 30292850 Free article. Clinical Trial.
Randomised phase II trial of 4 dose levels of single agent docetaxel in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC): DOC PS2 trial. Manchester lung cancer group.
Califano R, Griffiths R, Lorigan P, Ashcroft L, Taylor P, Burt P, Lee L, Chittalia A, Harris M, Faivre-Finn C, Thatcher N, Blackhall F. Califano R, et al. Among authors: taylor p. Lung Cancer. 2011 Sep;73(3):338-44. doi: 10.1016/j.lungcan.2011.01.001. Epub 2011 Feb 5. Lung Cancer. 2011. PMID: 21296449 Clinical Trial.
Prophylactic Irradiation of Tracts in Patients With Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial.
Bayman N, Appel W, Ashcroft L, Baldwin DR, Bates A, Darlison L, Edwards JG, Ezhil V, Gilligan D, Hatton M, Jegannathen A, Mansy T, Peake MD, Pemberton L, Rintoul RC, Snee M, Ryder WD, Taylor P, Faivre-Finn C. Bayman N, et al. Among authors: taylor p. J Clin Oncol. 2019 May 10;37(14):1200-1208. doi: 10.1200/JCO.18.01678. Epub 2019 Mar 28. J Clin Oncol. 2019. PMID: 30920878 Free article. Clinical Trial.
Availability of EGFR mutation status at first oncology consultation for advanced non-squamous non-small cell lung cancer patients. A pilot experience from the Christie.
Evans M, Summers Y, Taylor P, Harris M, Bayman N, Faivre-Finn C, Sheikh H, Burt P, Blackhall F, Califano R. Evans M, et al. Among authors: taylor p. Lung Cancer. 2013 Dec;82(3):510-1. doi: 10.1016/j.lungcan.2013.09.006. Epub 2013 Sep 21. Lung Cancer. 2013. PMID: 24138902 No abstract available.
Thymidylate synthase expression and outcome of patients receiving pemetrexed for advanced nonsquamous non-small-cell lung cancer in a prospective blinded assessment phase II clinical trial.
Nicolson MC, Fennell DA, Ferry D, O'Byrne K, Shah R, Potter V, Skailes G, Upadhyay S, Taylor P, André V, Nguyen TS, Myrand SP, Visseren-Grul C, Das M, Kerr KM. Nicolson MC, et al. Among authors: taylor p. J Thorac Oncol. 2013 Jul;8(7):930-9. doi: 10.1097/JTO.0b013e318292c500. J Thorac Oncol. 2013. PMID: 23722170 Free article. Clinical Trial.
6,242 results